The paper presents a multi-agent system called nanoagent for automating molecular docking in drug discovery, significantly reducing the time traditionally required for this process. With 80% accuracy and 95% efficiency compared to manual methods, nanoagent operates autonomously through agents that manage various aspects of the docking process, utilizing existing data from protein databases. The research highlights the advantages of multi-agent technology over previous semi-automated approaches, showing potential for further advancements in drug development.
Related topics: